← Back to all trials
Withdrawn
NCT04674735
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
Conditions: Meniere Disease, Vertigo, Vertigo Vestibular
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE1
Sponsor: Apsen Farmaceutica S.A.
Summary
The purpose of this study is to evaluate the safety of APSLXR in participants with Meniere's disease or other Verigo of vestibular origin. Pharmacokinetics will also be evaluated in a small group.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Meniere's Disease or Vertigo of Vestibular Origin;
* Voluntarily consent to participate in the study;
Exclusion Criteria:
* Female patients who are pregnant or breastfeeding;
* Participants presenting uncontroled systolic hipertension (\>140/90 mmHg);
* Participants presenting uncontroled diabetes (blood glucose \>200 mg/dL).
Source: ClinicalTrials.gov (NCT04674735). StuddyBuddy aggregates publicly available trial information.
